Dongrui R. Lu

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Dongrui R. Lu

Oct 31, 2024, 07:36 | Blog

Erika Hamilton: Novel endocrine agents are coming

Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Jul 31, 2024, 03:15 | Blog

Erika Hamilton: Happy to get the word out about the VERITAC2 trial

Erika Hamilton posted on LinkedIn about a recent paper, titled "VERITAC-2: a Phase III study of…

Jul 14, 2024, 22:09 | Blog

Maggie Cheang: Intrinsic subtypes with survival outcomes on CDK4/6 inhibitors

Maggie Cheang, Team Leader of Genomic Analysis - Clinical Trials at The Institute of Cancer Research,…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023